Adverse events of subcutaneous recombinant human erythropoietin therapy.
Klinkmann
H
H
Department of Internal Medicine, University of Rostock, FRG.
Schmidt
R
R
Wieczorek
L
L
Scigalla
P
P
D002319:Cardiovascular System / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006400:Hematocrit; D006801:Humans; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy / Q000628:therapy; D008297:Male; D006435:Renal Dialysis; D012137:Respiratory System / Q000187:drug effects; D012449:Safety
D004921:Erythropoietin